Medical Care
Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2026
- May 01, 26
- ID: 690028
- Pages: 119
- Figures: 119
- Views: 8
This report delivers a comprehensive overview of the global Viral Vectors and Plasmid DNA Manufacturing market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Viral Vectors and Plasmid DNA Manufacturing. The Viral Vectors and Plasmid DNA Manufacturing market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Viral Vectors and Plasmid DNA Manufacturing market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Viral Vectors and Plasmid DNA Manufacturing manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Thermo Fisher Scientific
Lonza
Azenta Life Sciences
Revvity
VectorBuilder
Takara Bio
GenScript Biotech
Gene Chem
Geno Meditech
PackGene Biotech
VIROVEK
OriGen
Vector BioLabs
Segment by Type
AAV
Lentiviruses
Retroviruses
Adenoviruses
DNA Plasmids
Other
Segment by Application
Pharmaceutical and Biopharmaceutical Companies
Academics and Research Institutes
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Viral Vectors and Plasmid DNA Manufacturing companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
The report segments the global Viral Vectors and Plasmid DNA Manufacturing market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Viral Vectors and Plasmid DNA Manufacturing manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Thermo Fisher Scientific
Lonza
Azenta Life Sciences
Revvity
VectorBuilder
Takara Bio
GenScript Biotech
Gene Chem
Geno Meditech
PackGene Biotech
VIROVEK
OriGen
Vector BioLabs
Segment by Type
AAV
Lentiviruses
Retroviruses
Adenoviruses
DNA Plasmids
Other
Segment by Application
Pharmaceutical and Biopharmaceutical Companies
Academics and Research Institutes
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Viral Vectors and Plasmid DNA Manufacturing companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 AAV
1.2.3 Lentiviruses
1.2.4 Retroviruses
1.2.5 Adenoviruses
1.2.6 DNA Plasmids
1.2.7 Other
1.3 Market by Application
1.3.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Pharmaceutical and Biopharmaceutical Companies
1.3.3 Academics and Research Institutes
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Perspective (2021–2032)
2.2 Global Viral Vectors and Plasmid DNA Manufacturing Growth Trends by Region
2.2.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Viral Vectors and Plasmid DNA Manufacturing Historic Market Size by Region (2021–2026)
2.2.3 Viral Vectors and Plasmid DNA Manufacturing Forecasted Market Size by Region (2027–2032)
2.3 Viral Vectors and Plasmid DNA Manufacturing Market Dynamics
2.3.1 Viral Vectors and Plasmid DNA Manufacturing Industry Trends
2.3.2 Viral Vectors and Plasmid DNA Manufacturing Market Drivers
2.3.3 Viral Vectors and Plasmid DNA Manufacturing Market Challenges
2.3.4 Viral Vectors and Plasmid DNA Manufacturing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Viral Vectors and Plasmid DNA Manufacturing Players by Revenue
3.1.1 Global Top Viral Vectors and Plasmid DNA Manufacturing Players by Revenue (2021–2026)
3.1.2 Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Players (2021–2026)
3.2 Global Top Viral Vectors and Plasmid DNA Manufacturing Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Viral Vectors and Plasmid DNA Manufacturing Revenue
3.4 Global Viral Vectors and Plasmid DNA Manufacturing Market Concentration Ratio
3.4.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Viral Vectors and Plasmid DNA Manufacturing Revenue in 2025
3.5 Global Key Players of Viral Vectors and Plasmid DNA Manufacturing Head Offices and Areas Served
3.6 Global Key Players of Viral Vectors and Plasmid DNA Manufacturing, Products and Applications
3.7 Global Key Players of Viral Vectors and Plasmid DNA Manufacturing, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Viral Vectors and Plasmid DNA Manufacturing Breakdown Data by Type
4.1 Global Viral Vectors and Plasmid DNA Manufacturing Historic Market Size by Type (2021–2026)
4.2 Global Viral Vectors and Plasmid DNA Manufacturing Forecasted Market Size by Type (2027–2032)
5 Viral Vectors and Plasmid DNA Manufacturing Breakdown Data by Application
5.1 Global Viral Vectors and Plasmid DNA Manufacturing Historic Market Size by Application (2021–2026)
5.2 Global Viral Vectors and Plasmid DNA Manufacturing Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Viral Vectors and Plasmid DNA Manufacturing Market Size (2021–2032)
6.2 North America Viral Vectors and Plasmid DNA Manufacturing Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2021–2026)
6.4 North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size (2021–2032)
7.2 Europe Viral Vectors and Plasmid DNA Manufacturing Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2021–2026)
7.4 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size (2021–2032)
8.2 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size by Region (2021–2026)
8.4 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size (2021–2032)
9.2 Latin America Viral Vectors and Plasmid DNA Manufacturing Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2021–2026)
9.4 Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size (2021–2032)
10.2 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2021–2026)
10.4 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Viral Vectors and Plasmid DNA Manufacturing Introduction
11.1.4 Thermo Fisher Scientific Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Lonza
11.2.1 Lonza Company Details
11.2.2 Lonza Business Overview
11.2.3 Lonza Viral Vectors and Plasmid DNA Manufacturing Introduction
11.2.4 Lonza Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)
11.2.5 Lonza Recent Development
11.3 Azenta Life Sciences
11.3.1 Azenta Life Sciences Company Details
11.3.2 Azenta Life Sciences Business Overview
11.3.3 Azenta Life Sciences Viral Vectors and Plasmid DNA Manufacturing Introduction
11.3.4 Azenta Life Sciences Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)
11.3.5 Azenta Life Sciences Recent Development
11.4 Revvity
11.4.1 Revvity Company Details
11.4.2 Revvity Business Overview
11.4.3 Revvity Viral Vectors and Plasmid DNA Manufacturing Introduction
11.4.4 Revvity Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)
11.4.5 Revvity Recent Development
11.5 VectorBuilder
11.5.1 VectorBuilder Company Details
11.5.2 VectorBuilder Business Overview
11.5.3 VectorBuilder Viral Vectors and Plasmid DNA Manufacturing Introduction
11.5.4 VectorBuilder Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)
11.5.5 VectorBuilder Recent Development
11.6 Takara Bio
11.6.1 Takara Bio Company Details
11.6.2 Takara Bio Business Overview
11.6.3 Takara Bio Viral Vectors and Plasmid DNA Manufacturing Introduction
11.6.4 Takara Bio Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)
11.6.5 Takara Bio Recent Development
11.7 GenScript Biotech
11.7.1 GenScript Biotech Company Details
11.7.2 GenScript Biotech Business Overview
11.7.3 GenScript Biotech Viral Vectors and Plasmid DNA Manufacturing Introduction
11.7.4 GenScript Biotech Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)
11.7.5 GenScript Biotech Recent Development
11.8 Gene Chem
11.8.1 Gene Chem Company Details
11.8.2 Gene Chem Business Overview
11.8.3 Gene Chem Viral Vectors and Plasmid DNA Manufacturing Introduction
11.8.4 Gene Chem Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)
11.8.5 Gene Chem Recent Development
11.9 Geno Meditech
11.9.1 Geno Meditech Company Details
11.9.2 Geno Meditech Business Overview
11.9.3 Geno Meditech Viral Vectors and Plasmid DNA Manufacturing Introduction
11.9.4 Geno Meditech Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)
11.9.5 Geno Meditech Recent Development
11.10 PackGene Biotech
11.10.1 PackGene Biotech Company Details
11.10.2 PackGene Biotech Business Overview
11.10.3 PackGene Biotech Viral Vectors and Plasmid DNA Manufacturing Introduction
11.10.4 PackGene Biotech Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)
11.10.5 PackGene Biotech Recent Development
11.11 VIROVEK
11.11.1 VIROVEK Company Details
11.11.2 VIROVEK Business Overview
11.11.3 VIROVEK Viral Vectors and Plasmid DNA Manufacturing Introduction
11.11.4 VIROVEK Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)
11.11.5 VIROVEK Recent Development
11.12 OriGen
11.12.1 OriGen Company Details
11.12.2 OriGen Business Overview
11.12.3 OriGen Viral Vectors and Plasmid DNA Manufacturing Introduction
11.12.4 OriGen Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)
11.12.5 OriGen Recent Development
11.13 Vector BioLabs
11.13.1 Vector BioLabs Company Details
11.13.2 Vector BioLabs Business Overview
11.13.3 Vector BioLabs Viral Vectors and Plasmid DNA Manufacturing Introduction
11.13.4 Vector BioLabs Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)
11.13.5 Vector BioLabs Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 AAV
1.2.3 Lentiviruses
1.2.4 Retroviruses
1.2.5 Adenoviruses
1.2.6 DNA Plasmids
1.2.7 Other
1.3 Market by Application
1.3.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Pharmaceutical and Biopharmaceutical Companies
1.3.3 Academics and Research Institutes
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Perspective (2021–2032)
2.2 Global Viral Vectors and Plasmid DNA Manufacturing Growth Trends by Region
2.2.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Viral Vectors and Plasmid DNA Manufacturing Historic Market Size by Region (2021–2026)
2.2.3 Viral Vectors and Plasmid DNA Manufacturing Forecasted Market Size by Region (2027–2032)
2.3 Viral Vectors and Plasmid DNA Manufacturing Market Dynamics
2.3.1 Viral Vectors and Plasmid DNA Manufacturing Industry Trends
2.3.2 Viral Vectors and Plasmid DNA Manufacturing Market Drivers
2.3.3 Viral Vectors and Plasmid DNA Manufacturing Market Challenges
2.3.4 Viral Vectors and Plasmid DNA Manufacturing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Viral Vectors and Plasmid DNA Manufacturing Players by Revenue
3.1.1 Global Top Viral Vectors and Plasmid DNA Manufacturing Players by Revenue (2021–2026)
3.1.2 Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Players (2021–2026)
3.2 Global Top Viral Vectors and Plasmid DNA Manufacturing Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Viral Vectors and Plasmid DNA Manufacturing Revenue
3.4 Global Viral Vectors and Plasmid DNA Manufacturing Market Concentration Ratio
3.4.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Viral Vectors and Plasmid DNA Manufacturing Revenue in 2025
3.5 Global Key Players of Viral Vectors and Plasmid DNA Manufacturing Head Offices and Areas Served
3.6 Global Key Players of Viral Vectors and Plasmid DNA Manufacturing, Products and Applications
3.7 Global Key Players of Viral Vectors and Plasmid DNA Manufacturing, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Viral Vectors and Plasmid DNA Manufacturing Breakdown Data by Type
4.1 Global Viral Vectors and Plasmid DNA Manufacturing Historic Market Size by Type (2021–2026)
4.2 Global Viral Vectors and Plasmid DNA Manufacturing Forecasted Market Size by Type (2027–2032)
5 Viral Vectors and Plasmid DNA Manufacturing Breakdown Data by Application
5.1 Global Viral Vectors and Plasmid DNA Manufacturing Historic Market Size by Application (2021–2026)
5.2 Global Viral Vectors and Plasmid DNA Manufacturing Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Viral Vectors and Plasmid DNA Manufacturing Market Size (2021–2032)
6.2 North America Viral Vectors and Plasmid DNA Manufacturing Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2021–2026)
6.4 North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size (2021–2032)
7.2 Europe Viral Vectors and Plasmid DNA Manufacturing Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2021–2026)
7.4 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size (2021–2032)
8.2 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size by Region (2021–2026)
8.4 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size (2021–2032)
9.2 Latin America Viral Vectors and Plasmid DNA Manufacturing Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2021–2026)
9.4 Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size (2021–2032)
10.2 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2021–2026)
10.4 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Viral Vectors and Plasmid DNA Manufacturing Introduction
11.1.4 Thermo Fisher Scientific Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Lonza
11.2.1 Lonza Company Details
11.2.2 Lonza Business Overview
11.2.3 Lonza Viral Vectors and Plasmid DNA Manufacturing Introduction
11.2.4 Lonza Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)
11.2.5 Lonza Recent Development
11.3 Azenta Life Sciences
11.3.1 Azenta Life Sciences Company Details
11.3.2 Azenta Life Sciences Business Overview
11.3.3 Azenta Life Sciences Viral Vectors and Plasmid DNA Manufacturing Introduction
11.3.4 Azenta Life Sciences Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)
11.3.5 Azenta Life Sciences Recent Development
11.4 Revvity
11.4.1 Revvity Company Details
11.4.2 Revvity Business Overview
11.4.3 Revvity Viral Vectors and Plasmid DNA Manufacturing Introduction
11.4.4 Revvity Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)
11.4.5 Revvity Recent Development
11.5 VectorBuilder
11.5.1 VectorBuilder Company Details
11.5.2 VectorBuilder Business Overview
11.5.3 VectorBuilder Viral Vectors and Plasmid DNA Manufacturing Introduction
11.5.4 VectorBuilder Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)
11.5.5 VectorBuilder Recent Development
11.6 Takara Bio
11.6.1 Takara Bio Company Details
11.6.2 Takara Bio Business Overview
11.6.3 Takara Bio Viral Vectors and Plasmid DNA Manufacturing Introduction
11.6.4 Takara Bio Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)
11.6.5 Takara Bio Recent Development
11.7 GenScript Biotech
11.7.1 GenScript Biotech Company Details
11.7.2 GenScript Biotech Business Overview
11.7.3 GenScript Biotech Viral Vectors and Plasmid DNA Manufacturing Introduction
11.7.4 GenScript Biotech Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)
11.7.5 GenScript Biotech Recent Development
11.8 Gene Chem
11.8.1 Gene Chem Company Details
11.8.2 Gene Chem Business Overview
11.8.3 Gene Chem Viral Vectors and Plasmid DNA Manufacturing Introduction
11.8.4 Gene Chem Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)
11.8.5 Gene Chem Recent Development
11.9 Geno Meditech
11.9.1 Geno Meditech Company Details
11.9.2 Geno Meditech Business Overview
11.9.3 Geno Meditech Viral Vectors and Plasmid DNA Manufacturing Introduction
11.9.4 Geno Meditech Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)
11.9.5 Geno Meditech Recent Development
11.10 PackGene Biotech
11.10.1 PackGene Biotech Company Details
11.10.2 PackGene Biotech Business Overview
11.10.3 PackGene Biotech Viral Vectors and Plasmid DNA Manufacturing Introduction
11.10.4 PackGene Biotech Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)
11.10.5 PackGene Biotech Recent Development
11.11 VIROVEK
11.11.1 VIROVEK Company Details
11.11.2 VIROVEK Business Overview
11.11.3 VIROVEK Viral Vectors and Plasmid DNA Manufacturing Introduction
11.11.4 VIROVEK Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)
11.11.5 VIROVEK Recent Development
11.12 OriGen
11.12.1 OriGen Company Details
11.12.2 OriGen Business Overview
11.12.3 OriGen Viral Vectors and Plasmid DNA Manufacturing Introduction
11.12.4 OriGen Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)
11.12.5 OriGen Recent Development
11.13 Vector BioLabs
11.13.1 Vector BioLabs Company Details
11.13.2 Vector BioLabs Business Overview
11.13.3 Vector BioLabs Viral Vectors and Plasmid DNA Manufacturing Introduction
11.13.4 Vector BioLabs Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)
11.13.5 Vector BioLabs Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of AAV
Table 3. Key Players of Lentiviruses
Table 4. Key Players of Retroviruses
Table 5. Key Players of Adenoviruses
Table 6. Key Players of DNA Plasmids
Table 7. Key Players of Other
Table 8. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 9. Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 10. Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Region (US$ Million), 2021–2026
Table 11. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Region (2021–2026)
Table 12. Global Viral Vectors and Plasmid DNA Manufacturing Forecasted Market Size by Region (US$ Million), 2027–2032
Table 13. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Region (2027–2032)
Table 14. Viral Vectors and Plasmid DNA Manufacturing Market Trends
Table 15. Viral Vectors and Plasmid DNA Manufacturing Market Drivers
Table 16. Viral Vectors and Plasmid DNA Manufacturing Market Challenges
Table 17. Viral Vectors and Plasmid DNA Manufacturing Market Restraints
Table 18. Global Viral Vectors and Plasmid DNA Manufacturing Revenue by Players (US$ Million), 2021–2026
Table 19. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Players (2021–2026)
Table 20. Global Top Viral Vectors and Plasmid DNA Manufacturing Players by Tier (Tier 1, Tier 2, and Tier 3), based on Viral Vectors and Plasmid DNA Manufacturing Revenue, 2025
Table 21. Ranking of Global Top Viral Vectors and Plasmid DNA Manufacturing Companies by Revenue (US$ Million) in 2025
Table 22. Global 5 Largest Players Market Share by Viral Vectors and Plasmid DNA Manufacturing Revenue (CR5 and HHI), 2021–2026
Table 23. Global Key Players of Viral Vectors and Plasmid DNA Manufacturing, Headquarters and Area Served
Table 24. Global Key Players of Viral Vectors and Plasmid DNA Manufacturing, Products and Applications
Table 25. Global Key Players of Viral Vectors and Plasmid DNA Manufacturing, Date of General Availability (GA)
Table 26. Mergers and Acquisitions, Expansion Plans
Table 27. Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (US$ Million), 2021–2026
Table 28. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Type (2021–2026)
Table 29. Global Viral Vectors and Plasmid DNA Manufacturing Forecasted Market Size by Type (US$ Million), 2027–2032
Table 30. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Type (2027–2032)
Table 31. Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (US$ Million), 2021–2026
Table 32. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Application (2021–2026)
Table 33. Global Viral Vectors and Plasmid DNA Manufacturing Forecasted Market Size by Application (US$ Million), 2027–2032
Table 34. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Application (2027–2032)
Table 35. North America Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 36. North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (US$ Million), 2021–2026
Table 37. North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (US$ Million), 2027–2032
Table 38. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 39. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (US$ Million), 2021–2026
Table 40. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (US$ Million), 2027–2032
Table 41. Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 42. Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size by Region (US$ Million), 2021–2026
Table 43. Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size by Region (US$ Million), 2027–2032
Table 44. Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 45. Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (US$ Million), 2021–2026
Table 46. Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (US$ Million), 2027–2032
Table 47. Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 48. Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (US$ Million), 2021–2026
Table 49. Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (US$ Million), 2027–2032
Table 50. Thermo Fisher Scientific Company Details
Table 51. Thermo Fisher Scientific Business Overview
Table 52. Thermo Fisher Scientific Viral Vectors and Plasmid DNA Manufacturing Product
Table 53. Thermo Fisher Scientific Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (US$ Million), 2021–2026
Table 54. Thermo Fisher Scientific Recent Development
Table 55. Lonza Company Details
Table 56. Lonza Business Overview
Table 57. Lonza Viral Vectors and Plasmid DNA Manufacturing Product
Table 58. Lonza Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (US$ Million), 2021–2026
Table 59. Lonza Recent Development
Table 60. Azenta Life Sciences Company Details
Table 61. Azenta Life Sciences Business Overview
Table 62. Azenta Life Sciences Viral Vectors and Plasmid DNA Manufacturing Product
Table 63. Azenta Life Sciences Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (US$ Million), 2021–2026
Table 64. Azenta Life Sciences Recent Development
Table 65. Revvity Company Details
Table 66. Revvity Business Overview
Table 67. Revvity Viral Vectors and Plasmid DNA Manufacturing Product
Table 68. Revvity Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (US$ Million), 2021–2026
Table 69. Revvity Recent Development
Table 70. VectorBuilder Company Details
Table 71. VectorBuilder Business Overview
Table 72. VectorBuilder Viral Vectors and Plasmid DNA Manufacturing Product
Table 73. VectorBuilder Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (US$ Million), 2021–2026
Table 74. VectorBuilder Recent Development
Table 75. Takara Bio Company Details
Table 76. Takara Bio Business Overview
Table 77. Takara Bio Viral Vectors and Plasmid DNA Manufacturing Product
Table 78. Takara Bio Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (US$ Million), 2021–2026
Table 79. Takara Bio Recent Development
Table 80. GenScript Biotech Company Details
Table 81. GenScript Biotech Business Overview
Table 82. GenScript Biotech Viral Vectors and Plasmid DNA Manufacturing Product
Table 83. GenScript Biotech Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (US$ Million), 2021–2026
Table 84. GenScript Biotech Recent Development
Table 85. Gene Chem Company Details
Table 86. Gene Chem Business Overview
Table 87. Gene Chem Viral Vectors and Plasmid DNA Manufacturing Product
Table 88. Gene Chem Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (US$ Million), 2021–2026
Table 89. Gene Chem Recent Development
Table 90. Geno Meditech Company Details
Table 91. Geno Meditech Business Overview
Table 92. Geno Meditech Viral Vectors and Plasmid DNA Manufacturing Product
Table 93. Geno Meditech Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (US$ Million), 2021–2026
Table 94. Geno Meditech Recent Development
Table 95. PackGene Biotech Company Details
Table 96. PackGene Biotech Business Overview
Table 97. PackGene Biotech Viral Vectors and Plasmid DNA Manufacturing Product
Table 98. PackGene Biotech Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (US$ Million), 2021–2026
Table 99. PackGene Biotech Recent Development
Table 100. VIROVEK Company Details
Table 101. VIROVEK Business Overview
Table 102. VIROVEK Viral Vectors and Plasmid DNA Manufacturing Product
Table 103. VIROVEK Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (US$ Million), 2021–2026
Table 104. VIROVEK Recent Development
Table 105. OriGen Company Details
Table 106. OriGen Business Overview
Table 107. OriGen Viral Vectors and Plasmid DNA Manufacturing Product
Table 108. OriGen Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (US$ Million), 2021–2026
Table 109. OriGen Recent Development
Table 110. Vector BioLabs Company Details
Table 111. Vector BioLabs Business Overview
Table 112. Vector BioLabs Viral Vectors and Plasmid DNA Manufacturing Product
Table 113. Vector BioLabs Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (US$ Million), 2021–2026
Table 114. Vector BioLabs Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
Table 118. Authors List of This Report
List of Figures
Figure 1. Viral Vectors and Plasmid DNA Manufacturing Picture
Figure 2. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Type: 2025 vs 2032
Figure 4. AAV Features
Figure 5. Lentiviruses Features
Figure 6. Retroviruses Features
Figure 7. Adenoviruses Features
Figure 8. DNA Plasmids Features
Figure 9. Other Features
Figure 10. Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (US$ Million), 2021–2032
Figure 11. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Application: 2025 vs 2032
Figure 12. Pharmaceutical and Biopharmaceutical Companies Case Studies
Figure 13. Academics and Research Institutes Case Studies
Figure 14. Viral Vectors and Plasmid DNA Manufacturing Report Years Considered
Figure 15. Global Viral Vectors and Plasmid DNA Manufacturing Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 16. Global Viral Vectors and Plasmid DNA Manufacturing Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 17. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Region: 2025 vs 2032
Figure 18. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Players in 2025
Figure 19. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 20. The Top 10 and 5 Players Market Share by Viral Vectors and Plasmid DNA Manufacturing Revenue in 2025
Figure 21. North America Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. North America Viral Vectors and Plasmid DNA Manufacturing Market Share by Country (2021–2032)
Figure 23. United States Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Canada Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. Europe Viral Vectors and Plasmid DNA Manufacturing Market Share by Country (2021–2032)
Figure 27. Germany Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. France Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. U.K. Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Italy Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Russia Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Ireland Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Share by Region (2021–2032)
Figure 35. China Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Japan Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. South Korea Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. India Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Australia & New Zealand Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Latin America Viral Vectors and Plasmid DNA Manufacturing Market Share by Country (2021–2032)
Figure 43. Mexico Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Brazil Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Share by Country (2021–2032)
Figure 47. Israel Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Saudi Arabia Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. UAE Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 50. Thermo Fisher Scientific Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)
Figure 51. Lonza Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)
Figure 52. Azenta Life Sciences Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)
Figure 53. Revvity Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)
Figure 54. VectorBuilder Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)
Figure 55. Takara Bio Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)
Figure 56. GenScript Biotech Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)
Figure 57. Gene Chem Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)
Figure 58. Geno Meditech Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)
Figure 59. PackGene Biotech Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)
Figure 60. VIROVEK Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)
Figure 61. OriGen Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)
Figure 62. Vector BioLabs Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Table 1. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of AAV
Table 3. Key Players of Lentiviruses
Table 4. Key Players of Retroviruses
Table 5. Key Players of Adenoviruses
Table 6. Key Players of DNA Plasmids
Table 7. Key Players of Other
Table 8. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 9. Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 10. Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Region (US$ Million), 2021–2026
Table 11. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Region (2021–2026)
Table 12. Global Viral Vectors and Plasmid DNA Manufacturing Forecasted Market Size by Region (US$ Million), 2027–2032
Table 13. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Region (2027–2032)
Table 14. Viral Vectors and Plasmid DNA Manufacturing Market Trends
Table 15. Viral Vectors and Plasmid DNA Manufacturing Market Drivers
Table 16. Viral Vectors and Plasmid DNA Manufacturing Market Challenges
Table 17. Viral Vectors and Plasmid DNA Manufacturing Market Restraints
Table 18. Global Viral Vectors and Plasmid DNA Manufacturing Revenue by Players (US$ Million), 2021–2026
Table 19. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Players (2021–2026)
Table 20. Global Top Viral Vectors and Plasmid DNA Manufacturing Players by Tier (Tier 1, Tier 2, and Tier 3), based on Viral Vectors and Plasmid DNA Manufacturing Revenue, 2025
Table 21. Ranking of Global Top Viral Vectors and Plasmid DNA Manufacturing Companies by Revenue (US$ Million) in 2025
Table 22. Global 5 Largest Players Market Share by Viral Vectors and Plasmid DNA Manufacturing Revenue (CR5 and HHI), 2021–2026
Table 23. Global Key Players of Viral Vectors and Plasmid DNA Manufacturing, Headquarters and Area Served
Table 24. Global Key Players of Viral Vectors and Plasmid DNA Manufacturing, Products and Applications
Table 25. Global Key Players of Viral Vectors and Plasmid DNA Manufacturing, Date of General Availability (GA)
Table 26. Mergers and Acquisitions, Expansion Plans
Table 27. Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (US$ Million), 2021–2026
Table 28. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Type (2021–2026)
Table 29. Global Viral Vectors and Plasmid DNA Manufacturing Forecasted Market Size by Type (US$ Million), 2027–2032
Table 30. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Type (2027–2032)
Table 31. Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (US$ Million), 2021–2026
Table 32. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Application (2021–2026)
Table 33. Global Viral Vectors and Plasmid DNA Manufacturing Forecasted Market Size by Application (US$ Million), 2027–2032
Table 34. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Application (2027–2032)
Table 35. North America Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 36. North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (US$ Million), 2021–2026
Table 37. North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (US$ Million), 2027–2032
Table 38. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 39. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (US$ Million), 2021–2026
Table 40. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (US$ Million), 2027–2032
Table 41. Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 42. Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size by Region (US$ Million), 2021–2026
Table 43. Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size by Region (US$ Million), 2027–2032
Table 44. Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 45. Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (US$ Million), 2021–2026
Table 46. Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (US$ Million), 2027–2032
Table 47. Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 48. Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (US$ Million), 2021–2026
Table 49. Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (US$ Million), 2027–2032
Table 50. Thermo Fisher Scientific Company Details
Table 51. Thermo Fisher Scientific Business Overview
Table 52. Thermo Fisher Scientific Viral Vectors and Plasmid DNA Manufacturing Product
Table 53. Thermo Fisher Scientific Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (US$ Million), 2021–2026
Table 54. Thermo Fisher Scientific Recent Development
Table 55. Lonza Company Details
Table 56. Lonza Business Overview
Table 57. Lonza Viral Vectors and Plasmid DNA Manufacturing Product
Table 58. Lonza Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (US$ Million), 2021–2026
Table 59. Lonza Recent Development
Table 60. Azenta Life Sciences Company Details
Table 61. Azenta Life Sciences Business Overview
Table 62. Azenta Life Sciences Viral Vectors and Plasmid DNA Manufacturing Product
Table 63. Azenta Life Sciences Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (US$ Million), 2021–2026
Table 64. Azenta Life Sciences Recent Development
Table 65. Revvity Company Details
Table 66. Revvity Business Overview
Table 67. Revvity Viral Vectors and Plasmid DNA Manufacturing Product
Table 68. Revvity Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (US$ Million), 2021–2026
Table 69. Revvity Recent Development
Table 70. VectorBuilder Company Details
Table 71. VectorBuilder Business Overview
Table 72. VectorBuilder Viral Vectors and Plasmid DNA Manufacturing Product
Table 73. VectorBuilder Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (US$ Million), 2021–2026
Table 74. VectorBuilder Recent Development
Table 75. Takara Bio Company Details
Table 76. Takara Bio Business Overview
Table 77. Takara Bio Viral Vectors and Plasmid DNA Manufacturing Product
Table 78. Takara Bio Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (US$ Million), 2021–2026
Table 79. Takara Bio Recent Development
Table 80. GenScript Biotech Company Details
Table 81. GenScript Biotech Business Overview
Table 82. GenScript Biotech Viral Vectors and Plasmid DNA Manufacturing Product
Table 83. GenScript Biotech Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (US$ Million), 2021–2026
Table 84. GenScript Biotech Recent Development
Table 85. Gene Chem Company Details
Table 86. Gene Chem Business Overview
Table 87. Gene Chem Viral Vectors and Plasmid DNA Manufacturing Product
Table 88. Gene Chem Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (US$ Million), 2021–2026
Table 89. Gene Chem Recent Development
Table 90. Geno Meditech Company Details
Table 91. Geno Meditech Business Overview
Table 92. Geno Meditech Viral Vectors and Plasmid DNA Manufacturing Product
Table 93. Geno Meditech Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (US$ Million), 2021–2026
Table 94. Geno Meditech Recent Development
Table 95. PackGene Biotech Company Details
Table 96. PackGene Biotech Business Overview
Table 97. PackGene Biotech Viral Vectors and Plasmid DNA Manufacturing Product
Table 98. PackGene Biotech Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (US$ Million), 2021–2026
Table 99. PackGene Biotech Recent Development
Table 100. VIROVEK Company Details
Table 101. VIROVEK Business Overview
Table 102. VIROVEK Viral Vectors and Plasmid DNA Manufacturing Product
Table 103. VIROVEK Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (US$ Million), 2021–2026
Table 104. VIROVEK Recent Development
Table 105. OriGen Company Details
Table 106. OriGen Business Overview
Table 107. OriGen Viral Vectors and Plasmid DNA Manufacturing Product
Table 108. OriGen Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (US$ Million), 2021–2026
Table 109. OriGen Recent Development
Table 110. Vector BioLabs Company Details
Table 111. Vector BioLabs Business Overview
Table 112. Vector BioLabs Viral Vectors and Plasmid DNA Manufacturing Product
Table 113. Vector BioLabs Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (US$ Million), 2021–2026
Table 114. Vector BioLabs Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
Table 118. Authors List of This Report
List of Figures
Figure 1. Viral Vectors and Plasmid DNA Manufacturing Picture
Figure 2. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Type: 2025 vs 2032
Figure 4. AAV Features
Figure 5. Lentiviruses Features
Figure 6. Retroviruses Features
Figure 7. Adenoviruses Features
Figure 8. DNA Plasmids Features
Figure 9. Other Features
Figure 10. Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (US$ Million), 2021–2032
Figure 11. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Application: 2025 vs 2032
Figure 12. Pharmaceutical and Biopharmaceutical Companies Case Studies
Figure 13. Academics and Research Institutes Case Studies
Figure 14. Viral Vectors and Plasmid DNA Manufacturing Report Years Considered
Figure 15. Global Viral Vectors and Plasmid DNA Manufacturing Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 16. Global Viral Vectors and Plasmid DNA Manufacturing Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 17. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Region: 2025 vs 2032
Figure 18. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Players in 2025
Figure 19. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 20. The Top 10 and 5 Players Market Share by Viral Vectors and Plasmid DNA Manufacturing Revenue in 2025
Figure 21. North America Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. North America Viral Vectors and Plasmid DNA Manufacturing Market Share by Country (2021–2032)
Figure 23. United States Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Canada Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. Europe Viral Vectors and Plasmid DNA Manufacturing Market Share by Country (2021–2032)
Figure 27. Germany Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. France Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. U.K. Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Italy Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Russia Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Ireland Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Share by Region (2021–2032)
Figure 35. China Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Japan Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. South Korea Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. India Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Australia & New Zealand Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Latin America Viral Vectors and Plasmid DNA Manufacturing Market Share by Country (2021–2032)
Figure 43. Mexico Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Brazil Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Share by Country (2021–2032)
Figure 47. Israel Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Saudi Arabia Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. UAE Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 50. Thermo Fisher Scientific Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)
Figure 51. Lonza Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)
Figure 52. Azenta Life Sciences Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)
Figure 53. Revvity Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)
Figure 54. VectorBuilder Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)
Figure 55. Takara Bio Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)
Figure 56. GenScript Biotech Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)
Figure 57. Gene Chem Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)
Figure 58. Geno Meditech Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)
Figure 59. PackGene Biotech Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)
Figure 60. VIROVEK Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)
Figure 61. OriGen Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)
Figure 62. Vector BioLabs Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Natural Cocoa Extracts Market Research Report 2026
May 01, 26
Global Semiconductor Switched Mode Power Supply Market Research Report 2026
May 01, 26
Global Silicone Coated Spandrel Glass Market Research Report 2026
May 01, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232